Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Clinical trial NCT00002988 · COMPLETED

Trial details

NCT number: NCT00002988
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1997-04-01
Primary completion: 2000-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.